On Sanofi's U.S. website, compare how Influenza and Respiratory Syncytial Virus (RSV) are described. For each, identify the primary affected population, the main protective measure highlighted, and the general impact or severity mentioned. Summarize the key differences in these descriptions.
Navigate to sanofi.com. From the 'Your Health' menu, navigate to the 'Vaccines' section. Click on 'Influenza' under 'Vaccines'. Extract the primary affected population, highlighted protective measure, and general impact/severity for Influenza. Return to the 'Vaccines' menu under 'Your Health'. Click on 'Respiratory Syncytial Virus' under 'Vaccines'. Extract the primary affected population, highlighted protective measure, and general impact/severity for RSV. Synthesize and present a comparative summary of the information for both diseases.
Successfully navigate to both the 'Influenza' and 'Respiratory Syncytial Virus' pages. For Influenza, state that it impacts 'people around the world,' the best protective measure is an 'annual flu vaccination,' and it leads to 'thousands of flu-related complications, hospitalizations, and deaths each year.' For Respiratory Syncytial Virus (RSV), state that it primarily targets 'babies,' emphasizes 'RSV prevention is awareness' and providing 'families... with resources and information' as protective measures, and causes 'serious lung infection.' Clearly present a comparative summary highlighting the differences in affected populations, protective measures, and general impact/severity for both diseases, based on the extracted information.